The impact of electronic medication administration records (e-MAR) on medication administration safety and nurses' work

电子用药记录(e-MAR)对用药安全和护士工作的影响

基本信息

  • 批准号:
    nhmrc : 455270
  • 负责人:
  • 金额:
    $ 49.05万
  • 依托单位:
  • 依托单位国家:
    澳大利亚
  • 项目类别:
    NHMRC Project Grants
  • 财政年份:
    2007
  • 资助国家:
    澳大利亚
  • 起止时间:
    2007-01-01 至 2009-12-31
  • 项目状态:
    已结题

项目摘要

The demands on health systems, both nationally and internationally, are growing, exacerbated by an ageing population and health workforce shortages. The incorporation of information technology into new health care delivery models promises both improvements in the safety and efficiency of care delivery. Medication errors are one of the most significant safety issues for health care systems. Medication management occupies a significant amount of nurses' time, and is also fraught with error potential. One-third of all medication errors that cause patient harm arise from medication administration errors (MAEs). Electronic medication administration records (e-MARs) provide the potential to make the administration of medications safer for patients by reducing error rates, and also by allowing nurses to more efficiently manage medication tasks. However there is very limited research from Australia or overseas which has examined whether they computerised system work and in fact reduce error rates or save nurses time. In this project we will conduct prospective, controlled observational studies to determine the effectiveness of an electronic medication administration record (e-MAR) to reduce MAEs and the amount of time nurses spend in the medication administration process. The project will apply innovative data collection tools using PDA software purpose-built for these studies which have undergone extensive pilot testing in clinical settings. The results will have important implications for hospitals across Australia and internationally as they consider the implementation of e-MARs. This research will provide the first comprehensive data of medication administration errors in Australia against which future preventative error strategies can be evaluated. The results will provide the evidence needed to develop recommendations about how to reduce MAEs and improve the design of e-MARs.
对国家和国际卫生系统的需求日益增长,而人口老龄化和卫生工作人员短缺又加剧了这一需求。将信息技术纳入新的医疗保健提供模式有望提高医疗保健提供的安全性和效率。用药错误是医疗保健系统最重要的安全问题之一。药物管理占用了大量的护士的时间,也充满了错误的可能性。在所有导致患者伤害的用药错误中,有三分之一来自给药错误(MAE)。电子给药记录(e-MAR)通过降低错误率以及允许护士更有效地管理药物任务,为患者提供了更安全的给药可能性。然而,来自澳大利亚或海外的研究非常有限,这些研究考察了他们是否将系统计算机化,实际上是否降低了错误率或节省了护士的时间。在本项目中,我们将进行前瞻性对照观察性研究,以确定电子给药记录(e-MAR)的有效性,以减少MAE和护士在给药过程中花费的时间。该项目将采用创新的数据收集工具,使用专门为这些研究设计的PDA软件,这些研究已经在临床环境中进行了广泛的试点测试。研究结果将对澳大利亚和国际上的医院在考虑实施e-MAR时产生重要影响。这项研究将提供澳大利亚首次全面的用药错误数据,以评估未来的预防性错误策略。研究结果将为如何减少MAE和改进e-MAR的设计提供必要的证据。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ms Margaret Williamson其他文献

Ms Margaret Williamson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ms Margaret Williamson', 18)}}的其他基金

The safety and effectiveness of hospital e-prescribing systems: a controlled time series study
医院电子处方系统的安全性和有效性:一项受控时间序列研究
  • 批准号:
    nhmrc : 400929
  • 财政年份:
    2006
  • 资助金额:
    $ 49.05万
  • 项目类别:
    NHMRC Project Grants

相似国自然基金

基于循证医学本体论的临床元数据语言研究
  • 批准号:
    30972549
  • 批准年份:
    2009
  • 资助金额:
    24.0 万元
  • 项目类别:
    面上项目
双原子分子高激发振转能级的精确研究
  • 批准号:
    10774105
  • 批准年份:
    2007
  • 资助金额:
    35.0 万元
  • 项目类别:
    面上项目
基于安全多方计算的抗强制电子选举协议研究
  • 批准号:
    60773114
  • 批准年份:
    2007
  • 资助金额:
    28.0 万元
  • 项目类别:
    面上项目

相似海外基金

Impact of race and ethnicity on outcomes in patients with hormone receptor-positive breast cancer treated with CDK4/6 inhibitors
种族和民族对接受 CDK4/6 抑制剂治疗的激素受体阳性乳腺癌患者预后的影响
  • 批准号:
    10762267
  • 财政年份:
    2023
  • 资助金额:
    $ 49.05万
  • 项目类别:
Impact of race and ethnicity on outcomes in patients with hormone receptor-positive breast cancer treated with CDK4/6 inhibitors
种族和民族对接受 CDK4/6 抑制剂治疗的激素受体阳性乳腺癌患者预后的影响
  • 批准号:
    10762047
  • 财政年份:
    2023
  • 资助金额:
    $ 49.05万
  • 项目类别:
Stepped Care, Peer-Delivered Intervention to Improve ART Adherence and SUD in Primary Care
阶梯式护理、同伴提供的干预措施可提高初级护理中的 ART 依从性和 SUD
  • 批准号:
    10675089
  • 财政年份:
    2022
  • 资助金额:
    $ 49.05万
  • 项目类别:
Role of Non-pharmacological Pain Treatments in Safe and Effective Opioid Tapering in Chronic Pain
非药物疼痛治疗在安全有效地逐渐减少慢性疼痛中阿片类药物的作用
  • 批准号:
    10620195
  • 财政年份:
    2022
  • 资助金额:
    $ 49.05万
  • 项目类别:
Applying Critical Race Theory to investigate the impact of COVID-19-related policy changes on racial/ethnic disparities in medication treatment for opioid use disorder
应用批判种族理论来调查与 COVID-19 相关的政策变化对阿片类药物使用障碍药物治疗中种族/民族差异的影响
  • 批准号:
    10594573
  • 财政年份:
    2022
  • 资助金额:
    $ 49.05万
  • 项目类别:
Maternal COVID-19 Vaccination and Lactation Outcomes
孕产妇 COVID-19 疫苗接种和哺乳结果
  • 批准号:
    10650285
  • 财政年份:
    2022
  • 资助金额:
    $ 49.05万
  • 项目类别:
Maternal COVID-19 Vaccination and Lactation Outcomes
孕产妇 COVID-19 疫苗接种和哺乳结果
  • 批准号:
    10770308
  • 财政年份:
    2022
  • 资助金额:
    $ 49.05万
  • 项目类别:
Maternal COVID-19 Vaccination and Lactation Outcomes
孕产妇 COVID-19 疫苗接种和哺乳结果
  • 批准号:
    10390754
  • 财政年份:
    2022
  • 资助金额:
    $ 49.05万
  • 项目类别:
Applying Critical Race Theory to investigate the impact of COVID-19-related policy changes on racial/ethnic disparities in medication treatment for opioid use disorder
应用批判种族理论来调查与 COVID-19 相关的政策变化对阿片类药物使用障碍药物治疗中种族/民族差异的影响
  • 批准号:
    10473098
  • 财政年份:
    2022
  • 资助金额:
    $ 49.05万
  • 项目类别:
Increasing Peer Support for OUD Recovery during COVID-19 through Digital Health: A National Randomized Controlled Trial
通过数字健康在 COVID-19 期间增加 OUD 恢复的同行支持:一项全国随机对照试验
  • 批准号:
    10672255
  • 财政年份:
    2021
  • 资助金额:
    $ 49.05万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了